# Phase 2 -- Review Round 3 Fix Report

Date: 2026-05-19
Scope: 1 finding from `phase-2-review-round3-findings-report.md`
Status: 1/1 addressed. Build clean, 6/6 tests passing.

---

## 1. R3-1 (LOW): Unused `expanded` state in `MeasureCard` — FIXED

**File**: `src/components/ReportBuilder/MeasureCard.tsx:5, 26-27`

**Root cause**: `useState(false)` for `expanded`/`setExpanded` was declared but neither value was ever read or called. The Phase 3 comment documented the intent, but the dead state triggered React strict mode warnings.

**Fix**:
- Removed `import { useState } from 'react'` from imports
- Removed `const [expanded, setExpanded] = useState(false)` and the `// Phase 3:` comment

The state will be re-added when the expanded view is implemented in Phase 3.

---

## 2. R3-2 (INFO): `checkTemplatePrerequisites` dead export

**File**: `src/utils/reportTemplates.ts:73-95`

**Status**: No action required. Documented for awareness. The function is exported but not imported anywhere (TemplatePicker does its own inline check). Tree-shaking eliminates it in production builds.

---

## 3. Verification

| Check | Result |
|-------|--------|
| TypeScript compilation (`tsc`) | Zero errors |
| Vite production build | Zero warnings |
| Unit tests (`vitest run`) | 6/6 passing |
| All 9 Round 2 fixes | Verified by reviewer |
| Dead imports in source | 0 |
| Dead state in source | 0 |

### Command Output

```
$ npm run build && npm test
> tsc && vite build
vite v5.4.21 building for production...
✓ 11589 modules transformed.
dist/index.html                  0.41 kB │ gzip:   0.28 kB
dist/assets/index-CALGLuj7.js  468.76 kB │ gzip: 143.86 kB
✓ built in 13.85s

> vitest run
 ✓ src/__tests__/excelFormulas.test.ts  (6 tests) 6ms
 Test Files  1 passed (1)
      Tests  6 passed (6)
```

---

## 4. Reviewer Conclusion

> "The Phase 2 codebase is now in a clean state. All Round 2 fixes verified. No high, medium, or security findings remaining. Phase 2 review can be concluded."

---

*End of Phase 2 Round 3 fix report. 1/1 finding addressed. Phase 2 review concluded.*
